文献速递心外重症与机械循环支持

左心室辅助装置植入时行左心耳封堵可减少血栓栓塞事件

Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events.
PubMed 文献 · Ann Thorac Surg · 2018-10-23

该回顾性研究纳入2013年1月至2014年1月首次植入连续流左心室辅助装置(LVAD)的102例患者,其中36例同期行左心耳封堵(LAAO),66例未行。中位随访306天,LAAO组血栓栓塞事件(TE)发生率显著低于非LAAO组(p=0.049),Cox分析显示LAAO与TE风险降低独立相关(HR 0.27,95%CI 0.08-0.95,p=0.04)。

要点

  • LVAD植入同期行LAAO与血栓栓塞事件减少相关。
  • LAAO组TE风险显著降低(HR 0.27,95%CI 0.08-0.95)。
  • 该效应可能独立于心房颤动,需前瞻性随机研究证实。

核心结论

  • 在LVAD植入患者中,LAAO与血栓栓塞事件减少相关,且该效应可能独立于心房颤动。

研究设计与样本

  • 回顾性分析2013年1月至2014年1月首次植入LVAD的102例患者,36例同期行LAAO,66例未行。

主要发现

  • LAAO组TE发生3例(1例装置血栓、2例脑血管意外),非LAAO组15例(5例装置血栓、11例脑血管意外),p=0.049。
  • Cox风险分析(纳入年龄、性别、高血压、心房颤动)显示LAAO组TE风险降低(HR 0.27,95%CI 0.08-0.95,p=0.04)。
  • 两组术前心房颤动比例无显著差异(LAAO组52.7% vs 非LAAO组54.5%,p=1.0)。
  • 两组除冠状动脉旁路移植史外(LAAO组8.3% vs 非LAAO组44%,p=0.0005),其他特征无显著差异。
  • 中位随访306天。

临床怎么用

  • 对于拟行LVAD植入的患者,可考虑同期行LAAO以降低血栓栓塞风险。

局限性

  • 为回顾性研究,需前瞻性随机研究证实LAAO预防TE的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thromboembolic events (TEs) are common adverse events with continuous-flow left ventricular assist devices (LVADs). Left atrial appendage occlusion (LAAO) is commonly performed at the time of a cardiac operation. The effect of LAAO on TEs in LVAD patients remains unknown. METHODS: All patients receiving a first LVAD implantation between January 2013 and January 2014 were reviewed. TEs included device thrombosis and ischemic cerebrovascular accidents. The incidence of TEs with respect to LAAO was evaluated using Kaplan-Meier and Cox proportional hazards analyses. RESULTS: The analysis included 102 patients, 36 of whom received LAAO and 66 did not. LAAO patients were an average age of 60 years, and 69.4% were men. Non-LAAO patients were an average age of 59.3 years, and 71.2% were men. There were no significant differences in characteristics other than history of coronary artery bypass grafting (8.3% of LAAO vs 44% of non-LAAO, p = 0.0005). Preoperative atrial fibrillation was present in 19 LAAO patients (52.7%) and in 36 non-LAAO patients (54.5%; p = 1.0). Patients were monitored for a median of 306 days. TEs occurred in 3 LAAO patients (1 device thrombosis and 2 cerebrovascular accidents) compared with 15 non-LAAO patients (5 device thromboses and 11 cerebrovascular accidents, p = 0.049). In a Cox hazards analysis including age, sex, hypertension, and atrial fibrillation, LAAO demonstrated a decreased risk of TE (hazard ratio, 0.27; 95% confidence interval, 0.08 to 0.95; p = 0.04). CONCLUSIONS: In patients undergoing LVAD implantation, LAAO is associated with reduced TEs, and this effect may be independent of atrial fibrillation. A prospective randomized study to examine the efficacy LAAO in prevention of TE is needed to confirm these findings.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Deshmukh A, Bhatia A, Sayer GT, et al. Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events. Ann Thorac Surg. 2018. PMID: 30365959. doi:10.1016/j.athoracsur.2018.09.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。